J&J Eyes Cost-Effectiveness In R&D; Scientists Trained In Health Economics
Executive Summary
Johnson & Johnson is training its drug discovery scientists in pharmacoeconomics as one way to help contain future drug costs, Pharmaceutical R&D Chairman Per Peterson said during the company's R&D day in New York May 26